MARKETSnap
  • Market Snapshots
    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
    • P/E Ratios
      • Large Caps
      • Absolute
      • Total Market PE
    • Stocks Performance
      • Large Caps
      • Absolute
    • Industries Performance
      • Industry
      • Sector
  • Analyze Stock
    • Analyze a stockAnalyze CVS →
    • FindStock Picks / Stock Screener
    • Value · CVSIntrinsic Value Calculator
    • Invest · CVSInvestment Case
    • Hold · CVS5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding
    Calculator
  • Investing Philosophy
  • More
    • Charts
    • Commodities
    • Currencies
    • Economic Indicators
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
CVS stock logo

CVS

CVS Health Corp.

$80.84
0.8
 (1%)
Exchange:  NYSE
Market Cap:  103.432B
Shares Outstanding:  1.267B
Delayed data
Overview
Earnings
Financials
Valuation
Chart

About The Company

Sector:  HealthcareView sector performance
Industry:  Medical – Healthcare PlansView industry performance
   
CEO:  J. David Joyner
Full Time Employees:  259500
Address: 
One CVS Drive
Woonsocket
RI
2895
US
Website:  https://www.cvshealth.com
CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

Click to read more…

Revenue Segmentation

Revenue by type

Log in to continue

Log in to see the complete revenue and geographic breakdown.

Log in — it's free

CVS full analysis

22/05/2026

Hey everyone, welcome back to the channel. Today we're diving deep into CVS Health, one of the biggest players in the healthcare space, and breaking down whether the stock still offers real value after its recent earnings beat and raised guidance. CVS has been on a roll lately with its insurance business finally showing signs of stability, and that's helped the whole portfolio turn a corner. The company just posted strong first-quarter results that beat estimates across pharmacy, retail, and…

Open MarketSnap Listen

Log in to continue

Log in to see the full analysis preview and audio links.

Log in — it's free

Industry Peers

TICKERCOMPANYMKT CAPP/EFWD P/EROIC
CVCVS logoCVSCVS Health Corp.103.4B10.39.88.0%
ELELV logoELVElevance Health Inc.85.2B18.313.57.5%
CICI logoCICigna Corporation71.4B13.18.87.4%
HUHUM logoHUMHumana Inc.46.8B43.440.74.4%
CNCNC logoCNCCentene Corp.31.6B24.112.11.9%
MOMOH logoMOHMolina Healthcare, Inc.10.4B—37.72.1%

EPS

Historical EPS and analyst estimates in one chart. Log in for the full interactive view and links to detailed estimates.

Log in to continue

Log in for the full EPS chart and links to analyst estimates.

Log in — it's free
View full analyst estimates

Earnings Call

Full text

Earnings transcript

Read the complete earnings call transcript.

AI summary

Key takeaways

Short, structured highlights from the call so you can focus on what matters.

2026/11/04 — 3 quarter 2026

Log in to continue

Log in to read the full transcript and AI-generated earnings summaries.

Log in — it's free
Income Statement
Balance Sheet
Cash Flow Statement
Analyst Estimates

Income Statement

Year202320242025
Revenue357,776,000372,809,000402,067,000
Gross Profit54,431,00051,401,00055,362,000
EBITDA18,197,00013,683,0009,861,000
Operating Income13,743,0008,516,0004,660,000
Net Income8,344,0004,614,0001,768,000

Log in to continue

Log in to see the income statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Balance Sheet

Year202320242025
Total Assets249,728,000253,215,000253,538,000
Total Liabilities173,092,000177,485,000178,156,000
Total Stockholders Equity76,461,00075,560,00075,214,000
Total Debt79,385,00082,920,00079,950,000
Cash and Cash Equivalents8,196,0008,586,0008,453,000

Log in to continue

Log in to see the balance sheet and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Cash Flow Statement

Year202320242025
Operating Cash Flow13,426,0009,107,00010,639,000
Capital Expenditure-3,031,000-2,781,000-2,832,000
Free Cash Flow10,395,0006,326,0007,807,000
Net Income8,368,0004,586,0001,728,000
Net Change in Cash-4,780,000359,000-172,000

Log in to continue

Log in to see the cash flow statement and 10 historical years.

Log in — it's free

(* All numbers are in thousands)

Analyst Estimates

Fiscal Year2030Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Low)482,617,299.523Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (High)521,081,155.317Research AccessResearch AccessResearch AccessResearch Access
Estimated Revenue (Avg)502,274,000Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Low)25,215,877.787Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (High)27,132,757.777Research AccessResearch AccessResearch AccessResearch Access
Estimated Ebitda (Avg)26,195,487.158Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Low)13,973,399.430Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (High)15,439,053.082Research AccessResearch AccessResearch AccessResearch Access
Estimated Net Income (Avg)14,722,412.441Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Low)10,674,543.072Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (High)11,525,287.722Research AccessResearch AccessResearch AccessResearch Access
Estimated SGA Expense (Avg)11,109,310.529Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Avg)11.580Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (High)12.150Research AccessResearch AccessResearch AccessResearch Access
Estimated EPS (Low)10.990Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated Revenue)10Research AccessResearch AccessResearch AccessResearch Access
Number of Analysts (Estimated EPS)11Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access to see up to 5 years of analyst estimates.

Create a free account

(* All numbers are in thousands)

Current Key Metrics

?Revenue
 (TTM)
: 
372.692B  ?P/S
 (TTM)
: 
0.27
?Net Income
 (TTM)
: 
4.614B  ?P/E
 (TTM)
: 
10.32
?Enterprise Value
 (TTM)
: 
177.88B  ?EV/FCF
 (TTM)
: 
11.43
?Dividend Yield
 (TTM)
: 
2.98%  ?Payout Ratio
 (TTM)
: 
30.97%
?ROE
 (TTM)
: 
14.13%  ?ROIC
 (TTM)
: 
8.05%
?Net Debt
 (TTM)
: 
71.832B  ?Debt/Equity
 (TTM)
: 
0.94
?P/B
 (TTM)
: 
1.42  ?Current Ratio
 (TTM)
: 
0.85

Log in to continue

Log in to see all key valuation metrics and ratios for this symbol.

Log in — it's free

Forward P/E Ratios

?

Forward P/E (Avg EPS estimate) — log in with Research Access for high/low estimates and the interactive table.

Forward P/E 1YResearch AccessResearch AccessResearch AccessResearch Access
9.76Research AccessResearch AccessResearch AccessResearch Access

Log in to continue

Log in with Research Access for forward P/E high/low estimates and the full multi-year table.

Create a free account

SWOT Analysis

Strengths (preview)

  • CVS Health maintains a diversified revenue base across pharmacy services, retail, and healthcare segments, supported by consistent operating cash flow generation as indicated in cash flow statement columns.
  • Strategic initiatives highlighted in the Q4 2024 earnings call target margin expansion and operational efficiency, contributing to adjusted EPS delivery amid industry pressures.
  • Solid balance sheet metrics, including retained earnings and total assets, provide capacity for ongoing capital expenditures and dividend payments.

Log in with Research Access for Weaknesses, Opportunities, Threats, and the complete SWOT.

Log in to continue

Log in with Research Access for the complete SWOT analysis.

Create a free account

At what price to buy it? -
Intrinsic Value Calculator

Based on current fundamentals and analyst forecasts, MarketSnap estimates CVS intrinsic value between $101.79 – $123.53 per share. This depends on revenue growth, margins, and discount rate.

This is an automatic estimate. The most reliable way to know fair value for your own assumptions is to run the calculator below.


Calculate CVS Intrinsic Value

Common questions about CVS valuation

Is CVS Health Corp. (CVS) overvalued or undervalued right now?

MarketSnap estimates intrinsic value for CVS Health Corp. (CVS) using its proprietary valuation methodology, which incorporates discounted cash flow (DCF) analysis together with long-term earnings and fundamentals assumptions. By comparing intrinsic value to the current market price, long-term investors can see whether the stock screens as potentially overvalued, fairly valued, or undervalued today.

Is CVS a buy, hold, or sell for long-term investors?

MarketSnap does not give one-word “buy” or “sell” calls. Instead, it shows whether CVS trades at a premium or discount to its estimated intrinsic value, how sensitive that value is to growth and margin assumptions, and how the stock fits into a diversified, long-term portfolio so investors can make their own buy, hold, or sell decision.

What is CVS’s P/E ratio?

You can see CVS’s trailing P/E (TTM) and forward P/E estimates in the Current Key Metrics and Forward P/E Ratios sections above. The P/E ratio compares the current share price to earnings per share and helps investors gauge valuation relative to earnings.

How is intrinsic value calculated for CVS?

MarketSnap uses its own valuation framework—not a generic spreadsheet DCF alone. Future cash flows and earnings are projected, discounted, and combined with MarketSnap’s methodology so intrinsic value reflects fundamentals and long-term assumptions. You can run your own inputs and see the result using the Intrinsic Value Calculator above.

Is CVS a good long-term investment?

Whether CVS fits a long-term portfolio depends on your assumptions about growth, margins, and risk. MarketSnap provides the metrics, intrinsic value calculator, and SWOT context so you can form your own view rather than rely on a single buy/sell rating.

Research tools for CVS Health Corp.

  • CVS Health Corp. intrinsic value calculatorEstimate what the business is worth
  • CVS Health Corp. 5-year outlookWhat has to go right, and what could go wrong
CVS

1-day price chart preview. Log in for 1W through 5Y ranges and period tabs.

Daily snapshot

1
MarketSnap

Trading Metrics:

Open: 80.95   Previous Close: 80.04
Day Low: 80.68   Day High: 82.3
Year Low: 69.51   Year High: 110.68
Price Avg 50: 88.71   Price Avg 200: 89.34
Volume: 10.64M   Average Volume: 9.076M

Log in to continue

Log in for multi-period charts (1W–5Y), period tabs, and the same layout as members.

Log in — it's free
See in Nexus

Relevant news

CVS Health Raised Its 2026 Outlook 3 Times, but Not Its Dividend
18-11-2026 10:17
CVS Health Raised Its 2026 Outlook 3 Times, but Not Its Dividend
CVS Breakup Won't Satisfy Washington. It Could Still Work for Wall Street.
13-11-2026 05:30
CVS Breakup Won't Satisfy Washington. It Could Still Work for Wall Street.
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock
11-11-2026 17:26
Here is What to Know Beyond Why CVS Health Corporation (CVS) is a Trending Stock
Here's Why CVS Health (CVS) is a Strong Momentum Stock
11-11-2026 17:21
Here's Why CVS Health (CVS) is a Strong Momentum Stock
CVS Health earns global recognition for industry-leading AI and technology innovation
11-11-2026 09:00
CVS Health earns global recognition for industry-leading AI and technology innovation
CVS Has Not Received Offers For the Retail Pharmacy Business, CEO Says
09-11-2026 16:52
CVS Has Not Received Offers For the Retail Pharmacy Business, CEO Says

DISCLAIMER: The stock market data provided on this website is for informational purposes only and is not intended for trading purposes. While we strive to provide accurate and timely information, we cannot guarantee that the information is accurate at the moment it is received or that it will continue to be accurate in the future. We are not responsible for any actions taken based on the information provided on this website. Always consult with a licensed financial professional before making any investment decisions.
Terms of Service

Copyright © 2025 MarketSnap. All rights reserved.

Pricing

How MarketSnap works

What’s new

Contact Us

Privacy Policy

Cookie Policy

Terms of Service

Hover Image
MARKETSnap

Market

🇺🇸 United States

Language

    • Gainers & Losers
    • Most Active & More
    • 52-Week High/Low
    • Dividends
      • Large Caps
      • Absolute
      • Total Market PE
      • Large Caps
      • Absolute
      • Industry
      • Sector
    • Analyze a stockAnalyze CVS →
    • FindStock Picks / Stock Screener
    • Value · CVSIntrinsic Value Calculator
    • Invest · CVSInvestment Case
    • Hold · CVS5-Year Outlook
  • Learn
  • Calendar
  • Investment Compounding Calculator
    • Charts
    • Commodities
    • Currencies
      • Inflation
      • Consumer Sentiment
      • Recession Probability
      • Treasury Rates
      • GDP
  • Investing Philosophy
  • Nexus
    • Recent Activity
      • Overview
      • My Valuations
      • My Investment Journal
      • Watchlists & Portfolio
    • Plans
    • Settings
    • Public profile ↗
  • Log in
  • Log out

Media

Watch Listen Read
Ask MarketSnap AI

MarketSnap AI Assistant

Uses MarketSnap data and this page

Ready

🔒 You are currently logged out

Login

It's free

MarketSnap Assistant · Tips
    MarketSnap

    Welcome to MarketSnap

    The AI-powered workspace for stock pickers.

    Continue with Google Continue with email

    Already a member? Sign in

    Find stocks·Value them·Build the case·Journal decisions·Track what changes

    Free to join. No card needed. Privacy Policy

    Create your free MarketSnap account Continue with Google
    Chat with us MarketSnap support · account, plans, settings, help
    How MarketSnap works

    The conversation above goes to the MarketSnap team with your message. We reply by e-mail.